Evidence map›Paper›PMID 35891335›Full record

ArticleViruses2022

The Importance of Secretor-Status in Norovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

Lisa Swartling, Elda Sparrelid, Per Ljungman, Ksenia Boriskina, Davide Valentini, Lennart Svensson, Johan Nordgren

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lisa SwartlingDepartment of Infectious Diseases, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Elda SparrelidDivision of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, 141 86 Stockholm, Sweden.
Per LjungmanDepartment of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Karolinska Comprehensive Cancer Center, 141 86 Stockholm, Sweden.ORCID 0000-0002-8281-3245
Ksenia BoriskinaDepartment of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Karolinska Comprehensive Cancer Center, 141 86 Stockholm, Sweden.
Davide ValentiniDepartment of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Karolinska Comprehensive Cancer Center, 141 86 Stockholm, Sweden.
Lennart SvenssonDivision of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, 58183 Linköping, Sweden.ORCID 0000-0001-9306-8458
Johan NordgrenDivision of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, 58183 Linköping, Sweden.ORCID 0000-0002-5349-2569
Karolinska University Hospital · SELinköping University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Caliciviridae InfectionsHematopoietic Stem Cell TransplantationNorovirusFecesGenotypeHumansRetrospective Studiesgenotypehematopoietic stem cell transplantationimmunocompromisednorovirussecretor statusseveritysusceptibility

Identifiers

PMID35891335
PMCPMC9318794
OpenAlexW4283359305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.